Melanoma / Skin Cancer Program Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Kaposis sarcoma Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Kaposis sarcoma
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Kaposis sarcoma
FED11061
Pace
Melanoma, skin Clinical Trials
A Multi-Center Study of High Dose Aldesleukin (Interleukin-2)+ Vemurafenib Therapy in Patients with BRAFV600 Mutation Positive Metastatic Melanoma
Melanoma, skin
F12115
Ernstoff
A Multi-Site Retrospective Observational Study Of Us Patients With Unresectable Or Metastatic Melanoma Receiving Ipilimumab (Yervoy®) As First-Line Therapy
Melanoma, skin
F13048
Ernstoff
A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence
Melanoma, skin
F12076
Ernstoff
A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecular or Histopathological Evidence of Metastases in the Sentinel Node
Melanoma, skin
W1008
Barth
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon α-2b for Resected High-Risk Melanoma
Melanoma, skin
E1609
Ernstoff
A Phase III, Double-Blind, Placebo-Controlled Study Of Vemurafenib Versus Vemurafenib Plus GDC-0973 In Previously Untreated Brafv600-Mutation Positive Patients With Unresectable Locally Advanced Or Metastatic Melanoma
Melanoma, skin
F12202
Ernstoff
A Randomized Phase II Study of Sequential Biotherapy With Aflibercept and High Dose IL-2 Versus High Dose IL-2 Alone in Patients With Inoperable Stage III or Stage IV Melanoma: Efficacy and Biomarker Study
Melanoma, skin
W11068
Ernstoff
A Randomized, Open-Label, Multicenter Phase II Study of Ipilimumab Retreatment versus Chemotherapy for Subjects with Advanced Melanoma who Progressed after Initially Achieving Disease Control with Ipilimumab Therapy
Melanoma, skin
F13013
Ernstoff
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Melanoma, skin
D0946
Bakitas
Phase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-4, N1a, 2a (microscopic) Melanoma
Melanoma, skin
E1697
Eisenberg
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Melanoma, skin
FED11061
Pace
The High-Dose Aldesleukin (IL-2) `Select` Trial: A Prospective Tissue Collection Protocol to Investigate Predictove Models of Response to High Dose IL-2 Treatment in Patients with Advanced Melanoma
Melanoma, skin
W1043
Ernstoff
Ultrasound Evaluation of Sentinel Lymph Nodes in Melanoma Patients and in Patients with Melanocytic Tumors of Unknown Metastastic Potential (MELTUMP) or Atypical Spitz Nevus (ASN): A Prospective Data Base
Melanoma, skin
D1012
Ernstoff
Understanding Risk of Recurrence of Melanoma at Time of Primary Diagnosis
Melanoma, skin
D12122
Ernstoff
Other Skin Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Skin
D0946
Bakitas
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Skin
FED11061
Pace
